Skip to content

Esperion Therapeutics, Inc. (ESPR) Insider Trading -- Recent Executive & Director Transactions

11 insiders reported 44 Form 4 transactions for Esperion Therapeutics, Inc. (ESPR) over the past 18 months (most recent 2026-07-13). Recent activity: CARROLL J MARTIN (Director) Sell 177,523 shares, Shepard Jay (Director) Sell 164,472 shares, THOMPSON JOHN CRAIG (Director) Sell 79,873 shares, Fischer Seth H. Z. (Director) Sell 141,023 shares, Hoffman Robert E. (Director) Sell 85,153 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-07-13CARROLL J MARTINDirectorSell177,523$0
2026-07-13Shepard JayDirectorSell164,472$0
2026-07-13THOMPSON JOHN CRAIGDirectorSell79,873$0
2026-07-13Fischer Seth H. Z.DirectorSell141,023$0
2026-07-13Hoffman Robert E.DirectorSell85,153$0
2026-07-13Koenig Sheldon L.President and CEOSell2.1M$0
2026-07-13Looker BenjaminChief Legal OfficerSell667,524$0
2026-07-13Halladay BenjaminChief Financial OfficerSell705,410$0
2026-07-13Harlow John B. Jr.Chief Commercial OfficerSell424,536$0
2026-06-18Looker BenjaminChief Legal OfficerSell11,824$37,364
2026-06-18Halladay BenjaminChief Financial OfficerSell10,773$34,043
2026-06-18Koenig Sheldon L.President and CEOSell53,588$169,338
2026-06-01THOMPSON JOHN CRAIGDirectorBuy79,873$0
2026-06-01CARROLL J MARTINDirectorBuy79,873$0
2026-06-01Fischer Seth H. Z.DirectorBuy79,873$0
2026-06-01Shepard JayDirectorBuy79,873$0
2026-06-01Hoffman Robert E.DirectorBuy79,873$0
2026-03-18Looker BenjaminChief Legal OfficerSell5,708$15,412
2026-03-18Halladay BenjaminChief Financial OfficerSell6,424$17,409
2026-03-18Koenig Sheldon L.President and CEOSell25,578$69,572
2026-03-16Koenig Sheldon L.President and CEOBuy723,760$0
2026-03-16Halladay BenjaminChief Financial OfficerBuy247,430$0
2026-03-16Looker BenjaminChief Legal OfficerBuy300,840$0
2026-01-21Looker BenjaminGeneral CounselSell1,689$4,864
2025-12-18Halladay BenjaminChief Financial OfficerSell7,337$26,927

Source: SEC Form 4 filings · as of 2026-07-13